You are here: Home Newsroom News Item Boots Online Doctor launches new oral Foundayo weight loss pill as demand for oral weight loss treatment grows

Boots Online Doctor launches new oral Foundayo weight loss pill as demand for oral weight loss treatment grows

24 August 2026
News Healthcare

Boots Online Doctor launches new oral Foundayo weight loss pill as demand for oral weight loss treatment grows

  • The launch of the new oral Foundayo weight loss pill gives eligible customers another treatment option alongside the Wegovy tablet and is available through Boots Online Doctor and in selected stores. 

  • Boots is expanding its approach to weight management, combining medication with online coaching, progress tracking, aftercare and dedicated weight loss journey spaces in more than 220 stores. 

24 August 2026: Boots Online Doctor is today launching the new oral Foundayo weight loss pill, giving eligible customers another licensed oral treatment option as demand for tablet-based weight loss medication continues to grow. 

The launch follows the introduction of the Wegovy tablet at Boots in July, which has attracted a new group of customers to its weight loss service. Since its launch, more than two thirds (67%) of customers accessing weight loss medication through Boots have been new to the service, while almost half (47%) of new customers are now choosing the Wegovy tablet.1 Boots has also seen an uplift in the proportion of male patients choosing the oral treatment compared with weight loss injections, highlighting how offering different treatment formats can help make weight management more accessible to a broader range of people. 

Now, with the launch of Foundayo, eligible customers have another once-daily oral treatment option to consider following a clinical assessment. The service starts from £79.20 for new eligible customers2 who can opt to collect their medication from selected Boots stores or have it delivered to their home. 

Foundayo is a once-daily oral weight loss medication containing the active ingredient orforglipron, which works by mimicking the action of the naturally occurring GLP-1 hormone. It helps regulate appetite, increase feelings of fullness and reduce hunger. Alongside existing oral treatment option Wegovy, Foundayo provides customers with an additional choice, offering the convenience of flexible dosing at any time of the day without specific fasting requirements. 

The expansion of Boots weight management treatment options forms part of a wider approach designed to help customers make informed decisions and build sustainable lifestyle changes alongside their treatment.  

Customers using Boots Online Doctor’s weight loss service can access a range of resources, including a 10-week free weight loss programme focused on sustainable lifestyle and behavioural changes, an app to track progress** and a free 12-month aftercare programme for customers who have stopped medication.*** 

In stores, customers can consult with a pharmacist on the most appropriate treatment for them, whilst also receiving support and guidance on their weight loss journey. A curated range of health, wellness and beauty products have also been brought together into dedicated spaces in more than 220 stores, to help customers navigate some of the changes that can accompany weight loss. 

Jamie Kerruish, Chief Healthcare Officer at Boots, said: “The introduction of the new oral Foundayo pill is another important development in a rapidly evolving weight-management landscape. Since launching the Wegovy tablet in July, we’ve seen strong interest in oral treatment, with many customers accessing weight loss medication through Boots for the first time. 

“Medication is just one part of a successful weight management journey. Through our online and in-store offering, we want to give customers access to the information, tools and resources they need to make informed choices and build healthier, more sustainable habits.” 

Dr David Gwynne, Medical Director at Boots Online Doctor, said: “Having another oral treatment option available gives customers and healthcare professionals greater choice when considering the most appropriate treatment approach. Weight management is not one-size-fits-all, and having clinically licensed options with different administration methods allows treatment decisions to be considered alongside an individual’s preferences, lifestyle and clinical needs. 

“It’s important to remember that weight loss medication is not a quick fix. Whether taken as a tablet or injection, the best outcomes are achieved when treatment is combined with healthy lifestyle changes, patient education and ongoing clinical supervision. Medication can be a valuable tool, but it works best as part of a broader, long-term approach to weight management.” 

*Access to treatment is subject to an online consultation with a clinician to assess suitability. Charges apply. Subject to availability 

**The app helps customers track weight and much more. Download from Apple and Google Play app stores.   

***Available to customers who've used the Boots Online Doctor Weight Loss Treatment service for at least 6 consecutive months. The aftercare programme will come into effect 2 months after your final month of treatment and will be available for 12 months thereafter. 

Pricing is dependent on the strength of the prescribed Foundayo pill:    

  • 0.8mg – £79.20 for new customers with discount code 20NEW (£99 for existing customers) 

  • 2.5mg – £119  

  • 5.5mg – £149  

  • 9mg – £169 

  • 14.5mg - £189 

  • 17.2mg - £199 

News

What’s new at Boots? Find out the latest updates from the UK’s largest pharmacy-led health and beauty chain – from new products and services to important business developments.

xx

Features

Take a closer look at our team members and the work they do, learn more about our corporate social responsibility initiatives and see how we work behind the scenes.

xx

About Boots:   

Boots is the UK’s leading health, wellness and beauty retailer with over 51,000 team members and over 1,800 stores, ranging from local community pharmacies to large health and beauty destinations.*  

Boots serves its customers and patients for life as the leading provider of healthcare on the high street, offering accessible wellness solutions and as the UK’s number one beauty destination. It offers an unrivalled depth and breadth of products, which incorporates its extensive own brand range and innovative portfolio of brands, including No7, the UK’s No1 skincare brand, Soap & Glory, Liz Earle Beauty and Sleek MakeUP.    

Boots is part of The Boots Group, which is a trusted leader in healthcare, pharmacy and retail.  More company information is available on boots-uk.com.   

*Figures accurate as of 28 February 2026